Only logged-in users can see full content details
ZAGREB, Jan 25 (Hina) - Scientists from the Rudjer Boskovic Institute
(IRB) and its Biozyne company have developed a new method for
recognising the structure of drugs which is expected to enable
development of smart medicines used in chemotherapy and reduce the
cost and duration of experiments.